Forecast: Chemical Medicines Production in China

In 2023, the production of chemical medicines in China was valued at 3,220,000 metric tons, reflecting a 1.99% year-on-year increase. Over the period from 2013 to 2023, production showed fluctuations with significant declines in 2018 but overall moderate growth. From 2021 to 2023, the Compound Annual Growth Rate (CAGR) was 6.93%, indicating a resurgence in production output. The historical trends exhibit resilience despite occasional dips, notably the sharp decline in 2018, but depict an overall upward trajectory.

Looking forward, from 2024 to 2028, the forecast projects a steady growth in production with a 5-year CAGR of 1.26%. By 2028, the production is expected to reach 3,492,500 metric tons, representing a cumulative five-year growth rate of 6.49%. This suggests a stable yet modest growth pattern.

Future trends to watch for include:

• Technological advancements and their impact on production efficiency.
• Evolving regulatory frameworks within China and globally.
• Increasing domestic and global demand for chemical medicines.
• Market competition and potential consolidation within the industry.
• Environmental policies and their influence on production practices.